Cynthia Mubanga

8PUBLICATIONS
20CO-AUTHORS
Economic models and forecastingCrop and pasture protection (incl. pests, diseases and weeds)Infant and child healthMajor global burdens of diseaseElectrical energy generation (incl. renewables, excl. photovoltaics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 15, 2026
Evaluation of plasma anti-CS3 and anti-LTB IgG avidity among Zambian children vaccinated with ETVAX.

|Apr 27, 2024
Seroconversion and Kinetics of Vibriocidal Antibodies during the First 90 Days of Re-Vaccination with Oral Cholera Vaccine in an Endemic Population.

Caroline Cleopatra Chisenga, Bernard Phiri, Harriet Ng'ombe

|Mar 28, 2024
Application of a Novel Proteomic Microarray Reveals High Exposure to Diarrhoeagenic Escherichia coli among Children in Zambia Participating in a Phase I Clinical Trial.

Kapambwe Mwape, Cynthia Mubanga, Obvious Nchimunya Chilyabanyama

|Nov 25, 2023
Prevalence of Diarrhoeagenic Escherichia coli among Children Aged between 0-36 Months in Peri-Urban Areas of Lusaka.

Kapambwe Mwape, Samuel Bosomprah, Kennedy Chibesa

|Aug 26, 2023
Maternal and Infant Histo-Blood Group Antigen (HBGA) Profiles and Their Influence on Oral Rotavirus Vaccine (RotarixTM) Immunogenicity among Infants in Zambia.

Adriace Chauwa, Samuel Bosomprah, Natasha Makabilo Laban

|May 27, 2023
Use of an ETEC Proteome Microarray to Evaluate Cross-Reactivity of ETVAX® Vaccine-Induced IgG Antibodies in Zambian Children.

Cynthia Mubanga, Michelo Simuyandi, Kapambwe Mwape

Pageof 2

Frequent Collaborators

5 joint publications

Obvious Nchimunya Chilyabanyama

5 joint publications

Michelo Simuyandi

3 joint publications

Cleopatra Caroline Chisenga

3 joint publications

Natasha Makabilo Laban